Lupus/SLE

Currently recruiting studies


AbbVie M23-699 (SELECT-SLE) - Phase 3 Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants with Moderately to Severely Active SLE

Investigators: Dr. Ann Clarke, Dr. Megan Barber

Required age range: 18-99

Conditions: Lupus

Currently recruiting: Yes

More information/Key contact: Please email lead investigators for recruitment information.

Email lead investigators

ASTER: Anifrolumab Study for Treatment Effectiveness in the Real World Multi-National, Observational, Post-Launch Effectiveness Study

Investigator: Dr. Megan Barber

Required age range: 18-99

Conditions: Lupus

Currently recruiting: Yes

More information/Key contact: Visit study website here

View study website

BMS IM011-246 (POETYK SLE-1) - A Phase 3 Study to Evaluate the Safety and Efficacy of Deucravacitinib in Participants with Active SLE

Investigators: Dr. Ann Clarke, Dr. Megan Barber

Required age range: 18-99

Conditions: Lupus

Currently recruiting: Yes

More information/Key contact: Please email lead investigators for recruitment information.

Email lead investigators

Exploring Newcomer Experiences of SLE: Identifying Priorities and Developing Supports

Investigators: Dr. Ann Clarke, Dr. Megan Barber

Required age range: 18-99

Conditions: Lupus

Currently recruiting: Yes

More information/Key contact: Please email lead investigators for recruitment information.

Email lead investigators

Healthcare Utilization in Albertan Patients with Positive aPLs/APS and SLE

Investigators: Dr. Ann Clarke, Dr. Megan Barber

Required age range: 18-99

Conditions: APS, Lupus

Currently recruiting: Yes

More information/Key contact: Please email lead investigators for recruitment information.

Email lead investigators

International Prospective Cohort of SLE Pregnancies and Legacy Biobank

Investigators: Dr. Ann Clarke, Dr. Megan Barber

Required age range: 18-99

Conditions: Lupus, Pregnancy

Currently recruiting: Yes

More information/Key contact: Please email lead investigators for recruitment information.

Email lead investigators

LUPUS NEXUS LANDMARK STUDY: A PROSPECTIVE REGISTRY AND BIOREPOSITORY

Investigator: Dr. Ann Clarke

Required age range: 18-99

Conditions: Lupus

Currently recruiting: Yes

More information/Key contact: Visit study website here

View study website

Novartis CVAY736K12301 (SIRIUS-LN) - A Phase 3 Study to Evaluate Safety, Efficacy, and Tolerability of Ianalumab in Participants with Active LN

Investigators: Dr. Ann Clarke, Dr. Megan Barber

Required age range: 18-99

Conditions: APS, Lupus

Currently recruiting: Yes

More information/Key contact: Please email lead investigators for recruitment information.

Email lead investigators

Novartis CVAY736F12301 (SIRIUS-SLE) - A Phase 3 Study to Evaluate Safety, Efficacy, and Tolerability of Ianalumab in Participants with Active SLE

Investigators: Dr. Ann Clarke, Dr. Megan Barber

Required age range: 18-99

Conditions: APS, Lupus

Currently recruiting: Yes

More information/Key contact: Please email lead investigators for recruitment information.

Email lead investigators

Rheum4U - Precision Health Registry for Inflammatory Arthritis

Investigator: Dr. Dianne Mosher

Required age range: 16-99

Conditions: Gout, Arthritis, Rheumatoid Arthritis, Vasculitis, Lupus, Ankylosing Spondylitis

Currently recruiting: Yes

More information/Key contact: Visit study website here

View study website

Starlet - Southern Alberta Registry for Lupus Erythematosus

Investigator: Dr. Ann Clarke

Required age range: 18-99

Conditions: Lupus

Currently recruiting: Yes

More information/Key contact: Visit study website here

View study website

The Economic Challenges of SLE: Measuring and Mitigating the Impact

Investigators: Dr. Ann Clarke, Dr. Megan Barber

Required age range: 18-99

Conditions: Lupus, SLE

Currently recruiting: Yes

More information/Key contact: Please email lead investigators for recruitment information.

Email lead investigators

UCB SL0046 - A Phase 3 Extension Study to Assess the Long-Term Safety and Tolerability of Dapirolizumab Pegol Treatment in Study Participants with SLE

Investigators: Dr. Ann Clarke, Dr. Megan Barber

Required age range: 18-99

Conditions: Lupus

Currently recruiting: Yes

More information/Key contact: Please email lead investigators for recruitment information.

Email lead investigators

World - Southern Alberta Registry for Lupus Erythematosus

Investigator: Dr. Ann Clarke

Required age range: 18-99

Conditions: Lupus

Currently recruiting: Yes

More information/Key contact: Please email lead investigators for recruitment information.

Email lead investigator